These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12915985)

  • 1. [Therapy of olfactory loss].
    Hummel T
    Laryngorhinootologie; 2003 Aug; 82(8):552-4. PubMed ID: 12915985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoic acid in the treatment of smell dysfunction following viral infection of the upper respiratory tract.
    Hummel T; Heilmann S; Hüttenbriuk KB
    Laryngoscope; 2002 Nov; 112(11):2076-80. PubMed ID: 12439184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The quinoxaline derivative caroverine in the treatment of sensorineural smell disorders: a proof-of-concept study.
    Quint C; Temmel AF; Hummel T; Ehrenberger K
    Acta Otolaryngol; 2002 Dec; 122(8):877-81. PubMed ID: 12542209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of systemic or topical administration of corticosteroids and vitamin B in patients with olfactory loss].
    Heilmann S; Just T; Göktas O; Hauswald B; Hüttenbrink KB; Hummel T
    Laryngorhinootologie; 2004 Nov; 83(11):729-34. PubMed ID: 15538662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Local and systemic administration of corticosteroids in the treatment of olfactory loss.
    Heilmann S; Huettenbrink KB; Hummel T
    Am J Rhinol; 2004; 18(1):29-33. PubMed ID: 15035568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of ginkgo biloba and dexamethasone in the treatment of 3-methylindole-induced anosmia mouse model.
    Lee CH; Mo JH; Shim SH; Ahn JM; Kim JW
    Am J Rhinol; 2008; 22(3):292-6. PubMed ID: 18588762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of a conductive olfactory loss.
    Seiden AM; Duncan HJ
    Laryngoscope; 2001 Jan; 111(1):9-14. PubMed ID: 11192906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray.
    Seo BS; Lee HJ; Mo JH; Lee CH; Rhee CS; Kim JW
    Arch Otolaryngol Head Neck Surg; 2009 Oct; 135(10):1000-4. PubMed ID: 19841338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment for postviral olfactory dysfunction: a systematic review.
    Harless L; Liang J
    Int Forum Allergy Rhinol; 2016 Jul; 6(7):760-7. PubMed ID: 26879592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical therapy and smell dysfunction.
    Hellings PW; Rombaux P
    B-ENT; 2009; 5 Suppl 13():71-5. PubMed ID: 20084807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose, long-term caroverine administration attenuates impulse noise-induced hearing loss in the rat.
    Duan M; Chen Z; Qiu J; Ulfendahl M; Laurell G; Borg E; Ruan R
    Acta Otolaryngol; 2006 Dec; 126(11):1140-7. PubMed ID: 17050305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth.
    Steele JC; Bruce AJ; Drage LA; Rogers RS
    Oral Dis; 2008 Sep; 14(6):529-32. PubMed ID: 18266840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of therapy with alpha-lipoic acid (ALA) on the oxidative stress in the controlled NIDDM: a possible preventive way against the organ dysfunction?
    Gianturco V; Bellomo A; D'Ottavio E; Formosa V; Iori A; Mancinella M; Troisi G; Marigliano V
    Arch Gerontol Geriatr; 2009; 49 Suppl 1():129-33. PubMed ID: 19836626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trigeminal event-related potentials in patients with olfactory dysfunction.
    Rombaux P; Mouraux A; Keller T; Hummel T
    Rhinology; 2008 Sep; 46(3):170-4. PubMed ID: 18853866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of postinfectious olfactory disorders with minocycline: a double-blind, placebo-controlled study.
    Reden J; Herting B; Lill K; Kern R; Hummel T
    Laryngoscope; 2011 Mar; 121(3):679-82. PubMed ID: 21287560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study.
    Siwek M; Dudek D; Paul IA; Sowa-Kućma M; Zieba A; Popik P; Pilc A; Nowak G
    J Affect Disord; 2009 Nov; 118(1-3):187-95. PubMed ID: 19278731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness and feasibility of psychophysical and electrophysiological olfactory testing in the rhinology clinic.
    Rombaux P; Mouraux A; Collet S; Eloy P; Bertrand B
    Rhinology; 2009 Mar; 47(1):28-35. PubMed ID: 19382491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized double-blind placebo-controlled trial of thioctic acid in migraine prophylaxis.
    Magis D; Ambrosini A; Sándor P; Jacquy J; Laloux P; Schoenen J
    Headache; 2007 Jan; 47(1):52-7. PubMed ID: 17355494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.